North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report By Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), By End Use (Hospitals, Homecare), By Country, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The North America syringe infusion pumps market size was estimated at USD 645.1 million in 2024 and is projected to grow at a CAGR of 8.4% from 2025 to 2030. Market growth in the region is largely driven by the rising prevalence of chronic diseases, including cancer, cardiovascular disorders, diabetes, and respiratory illnesses. These conditions necessitate precise, continuous medication delivery, which syringe infusion pumps facilitate by allowing accurate dosing of critical medications such as chemotherapy agents and insulin. Given that approximately six in ten adults in North America are impacted by at least one chronic condition, the demand for reliable infusion devices in hospitals and outpatient care settings continues to escalate, underscoring the essential role of these pumps in patient management.

The increasing number of surgical procedures and admissions to intensive care units (ICUs) significantly contributes to the growth of the syringe infusion pump market. Syringe infusion pumps are vital in critical care environments, delivering precise dosages of anesthetics, analgesics, and vasoactive drugs during surgical operations and managing critically ill patients. According to a Washington Post article from March 2025, annual hospitalizations in the U.S. are estimated to increase from 36 million in 2025 to 40 million in 2035, further amplifying the necessity for dependable infusion devices ensuring accurate medication delivery.

Technological advancements in smart infusion technologies also play a crucial role in propelling market growth. The integration of features such as Dose Error Reduction Systems (DERS), wireless connectivity, and electronic health record (EHR) compatibility enhances both the safety and efficiency of medication administration. As North America leads in adopting these advanced infusion systems, healthcare providers benefit from improved adherence to protocols and reduced medication errors, thus enhancing clinical decision-making and patient safety.

The expansion of home healthcare and ambulatory care has fostered a growing demand for portable, user-friendly syringe pumps, fueled by the aging population and cost-containment strategies. Syringe infusion pumps facilitate safe medication delivery outside traditional hospital settings, significantly improving patient outcomes and quality of life. Coupled with favorable regulatory environments and reimbursement policies, these market dynamics ensure sustained growth and innovation within the North American region.

Disease Indication Insights

Pediatrics/neonatology dominated the market and accounted for a revenue share of 26.5% in 2024. The rising number of births, including preterm and low-birth-weight infants, has led to increased reliance on specialized infusion devices. Advances in smart pump technologies, equipped with features such as Dose Error Reduction Systems and EMR integration, have reduced medication errors. Expanded investment in NICUs and PICUs, coupled with stringent safety regulations, has further emphasized the critical role of syringe infusion pumps in delivering safe, effective care to vulnerable pediatric populations.

Chemotherapy is expected to grow at the fastest CAGR of 9.7% over the forecast period. Syringe infusion pumps play a critical role in oncology care by ensuring precision and accuracy in drug delivery, particularly for chemotherapy agents with narrow therapeutic windows. Their continuous and extended infusion capability enhances drug effectiveness while minimizing side effects. Modern pumps feature advanced safety technologies, including Dose Error Reduction Systems and alarms, significantly reducing medication errors. In 2024, the American Cancer Society projected over 2 million new cancer cases and 611,720 cancer deaths in the U.S., as detailed in their journal. Developments in portable ambulatory models are expected to enable patients to receive chemotherapy at home, improving quality of life and reducing costs, while supporting complex regimens and integrating with electronic health records for improved clinical workflow.

End Use Insights

Hospitals dominated the market and accounted for a revenue share of 40.5% in 2024. Hospitals, particularly critical care, oncology, and pediatric units, are exhibiting a high demand for precise syringe infusion pumps to ensure accurate, controlled delivery of small-volume medications crucial for complex therapies and error reduction. The diverse clinical applications in managing conditions such as cancer, cardiovascular diseases, and post-surgical pain, coupled with large patient volumes and skilled healthcare professionals capable of operating advanced systems, further drive the indispensable use of syringe pumps in hospital settings for chemotherapy, analgesia, and anesthesia.

Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period. The increasing prevalence of chronic diseases necessitates long-term, precise medication delivery, driving demand for homecare syringe infusion pumps, which facilitate safe therapy outside hospitals. The healthcare system’s shift towards ambulatory and home healthcare, supported by portable, user-friendly pumps, enhances patient convenience and reduces costs. Technological advancements, including connectivity and remote monitoring, improve safety and reliability. Cost-effectiveness, patient mobility, and favorable regulatory and reimbursement support further propel the adoption of syringe pumps for home infusion.

Country Insights

U.S. Syringe Infusion Pumps Market Trends

The U.S. syringe infusion pumps market dominated North America, with a revenue share of 81.5% in 2024. According to CDC data from February 2024, an estimated 129 million Americans are affected by at least one chronic illness. The high prevalence of chronic diseases necessitates precise medication delivery via syringe infusion pumps for conditions such as cancer and diabetes. The CDC states that many chronic conditions are preventable through simple lifestyle changes, such as smoking cessation, physical activity, and a healthy diet. An increase in the number of people suffering from chronic conditions is one of the key factors anticipated to boost the market over the forecast period.

According to the CMS, the national healthcare expenditure grew by 7.5% in 2023, facilitating the adoption of smart pumps featuring DERS and EHR integration. Technological innovation, supported by FDA approvals and a growing geriatric population requiring long-term infusions, further drives demand, alongside the expansion of home healthcare and favorable regulatory support. The U.S.’s large hospital base also contributes significantly to syringe pump utilization.

Canada Syringe Infusion Pumps Market Trends

Canada's syringe infusion pumps market is projected to grow significantly over the forecast period. The increasing prevalence of chronic diseases and a rise in surgical procedures and hospitalizations in Canada drive demand for precise syringe infusion pumps. Technological advancements, including smart features and EHR integration, enhance adoption. The growing preference for home healthcare and a favorable regulatory and reimbursement environment further support the wider utilization of these advanced infusion technologies.

Key North America Syringe Infusion Pumps Company Insights

Some key companies operating in the market include Baxter, B. Braun Medical Inc., Fresenius Kabi AG, ICU Medical, Inc., and Micrel Medical Devices SA. The market is intensely competitive, with key players utilizing technological innovations, FDA clearances, and strategic collaborations to maintain market leadership.

• ICU Medical offers syringe infusion pumps such as the Medfusion 4000. This wireless pump ensures precise, small-volume drug delivery with versatile syringe compatibility and seamless connectivity. It is widely utilized in critical care, pediatrics, and anesthesia to enhance safety and efficiency.  

• Micrel Medical Devices SA supplies advanced syringe infusion pumps, such as the Micropump MP mlh+ Multi Syringe, designed for hospital and homecare settings. These portable, user-friendly, and reliable devices support therapies such as pain management and immunoglobulin infusion, catering to outpatient and long-term care needs.

Recent Developments

• In November 2024, Boston Scientific Corporation announced an agreement to acquire Intera Oncology. This strategic acquisition aims to expand Boston Scientific’s interventional oncology offerings for treating liver-dominant metastases with Intera’s pump technology.

• In August 2024, Innovative Health Sciences expanded its commercial team to market the Insignis Syringe Infusion System. Having received FDA clearance in March 2024, this non-electric system offers precise flow control for intravenous and subcutaneous use across various settings.

• In April 2024, Baxter announced that the company received FDA clearance for its large volume infusion pump, Novum IQ, and Dose IQ Safety Software, integrating both large volume and syringe infusion capabilities on a single platform.

North America Syringe Infusion Pumps Market Report Scope

North America Syringe Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the North America syringe infusion pumps market report based on disease indication, end use, and country:

• Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Chemotherapy

  • Diabetes

  • Gastroenterology

  • Analgesia/Pain Management

  • Pediatrics/Neonatology

  • Hematology

  • Others

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Homecare

  • Others (ASC, Nursing Homes, Rehabilitation Centers)

• Country Outlook (Revenue, USD Billion, 2018 - 2030)

  • U.S.

  • Canada

  • Mexico